SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-017969
Filing Date
2023-02-10
Accepted
2023-02-10 08:00:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236146d1_sc13gaseq1.htm SC 13G/A 53701
  Complete submission text file 0001104659-23-017969.txt   54983
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Subject) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92695 | Film No.: 23608588
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCODE THERAPEUTICS, INC. 6 LIBERTY SQUARE, #2382 BOSTON MA 02109
Business Address
Medarova Zdravka (Filed by) CIK: 0001855758 (see all company filings)

Type: SC 13G/A